
Balancing Innovation and Risk in Healthtech
While new technologies may demonstrate clinical benefits in controlled settings, their true value is determined by how well they fit into existing healthcare workflows.
While new technologies may demonstrate clinical benefits in controlled settings, their true value is determined by how well they fit into existing healthcare workflows.
In this second of a two-part article, we'll cover common obstacles and offer insights on how to overcome these barriers to achieve success in the healthcare market.
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
This first of a two-part article examines key challenges healthcare technology companies must address to survive the “Death Valley” curve and increase their chances for success when moving from technology development to market acceptance.
Whether creating a health application or platform-based solutions, the effectiveness of innovation in healthtech relies not only on scientifically backed up technology, but more on consumer-driven design, highlighting the need for precision and efficiency.
Many medtech products, very often too technical and scientific, emphasize features at the expense of processes and their interactions. While the approach to patient and treatment safety is crucial, there is a notable shift towards processes centered around patients and healthcare professionals.